Unlocking the Radiologist's Role in Alzheimer's Diagnosis and Treatment 

Familiarize yourself with diagnostic tools and techniques that can be used to improve clinical outcomes for patients with Alzheimer's disease during this free, one-hour webinar. Experts will discuss the value of early diagnosis, the role of PET imaging in pathology, accurate monitoring/diagnosis of treatment-related side effects and communication strategies for interdisciplinary collaboration. This webinar is sponsored by Eli Lilly and Company. 

Register now



Webinar details 

Date & time: Oct. 23, 2024; noon–1 p.m. CT 
Price: Free 

This webinar will examine the radiologist’s role in achieving optimal clinical outcomes for patients with Alzheimer’s disease (AD). Many imaging physicians are unfamiliar with how to utilize diagnostic tools and implement evidence-based techniques to accurately monitor for and diagnose treatment-related side effects. Failure to accurately diagnose AD pathology and treatment-related side effects may lead to a delay in appropriate management and result in suboptimal clinical outcomes for the patient.  

Learning objectives 

  • Recognize the value of an early and accurate diagnosis of AD for optimal patient outcomes  
  • Discuss the role of PET imaging in the identification of AD pathology  
  • Implement evidence-based techniques to accurately monitor for and diagnose treatment-related side effects  
  • Develop and apply effective communication strategies for reporting imaging findings to the patient’s interdisciplinary team  

Speakers 

Jonathan E. McConathy, MD, PhD 
Director, Advanced Imaging Facility; Director, Division of Molecular Imaging and Therapeutics; Professor, Division of Molecular Imaging and Therapeutics
The University of Alabama at Birmingham

Jonathan E. McConathy, MD, PhD, is a radiologist and nuclear medicine physician who serves as the director of the division of molecular imaging and therapeutics, the director of the advanced imaging facility and leader of the imaging core of Alzheimer’s Disease Research Center at the University of Alabama at Birmingham. In addition to clinical practice in nuclear medicine, Dr. McConathy is involved in collaborative multimodality human imaging research with PET and MRI, including molecular neuroimaging in Alzheimer’s disease and related dementias, neuroinflammation imaging in Parkinson’s disease and PET tracer development for neuro-oncology. 

Cyrus A. Raji, MD, PhD    
Associate Professor of Radiology and Neurology   
Director, Neuromagnetic Resonance Imaging  
Associate Director, Radiology Research Track Residency  
Associate Leader, Knight ADRC Imaging Core  
Mallinckrodt Institute of Radiology | Washington University School of Medicine 

Cyrus A. Raji, MD, PhD, is an associate professor of radiology and a principal investigator in the Neuroimaging Labs Research Center at Mallinckrodt Institute of Radiology, the academic radiology department of Washington University School of Medicine in St. Louis. Dr. Raji, also an associate professor of neurology, serves as director of neuromagnetic resonance imaging at Barnes-Jewish Hospital and as associate director of the diagnostic radiology residency research track. He is board certified in diagnostic radiology and neuroradiology with research interests focused on modifiable risk factors for dementia and the role of advanced neuroimaging in quantitatively tracking related brain changes.

Maria Vittoria Spampinato, MD 
Professor of Radiology, Neuroradiology Division; Vice Chair Faculty Development; Neuroradiology Division Director 
Medical University of South Carolina 

Vittoria Spampinato, MD, is an academic radiologist and leader at the Medical University of South Carolina. In her roles as the vice chair of faculty development and neuroradiology division director, Vittoria’s mission is to advance neuroimaging services, train the next generation of health care professionals and promote the academic advancement and well-being of the radiology faculty.  

Register now

This webinar is sponsored by Eli Lilly and Company.